RICHMOND, Va.--(BUSINESS WIRE)--Insmed Inc. (Nasdaq:INSM), (referred to herein as “Insmed”, “we”, “our” and “us”), a biopharmaceutical company with unique protein process development and manufacturing experience and a proprietary protein platform aimed at niche markets with unmet medical needs, today announced results for the second quarter and six-month period ended June 30, 2007.
